GI tract

Guidelines (11)

Irritable Bowel Syndrome (NICE Guideline)

19 May 2017

Summary of NICE guidance on IBS.

Obeticholic Acid for Treating Primary Biliary Cholangitis (TA443)

26 April 2017

H.pylori: Eradication Regimens (NICE)

5 February 2016

Summary of NICE guidance on Helicobacter treatment.

Vedolizumab for Treating Moderately to Severely Active Crohn's Disease after Prior Therapy (TA352)

26 August 2015

Naloxegol for Treating Opioid-Induced Constipation (TA345)

22 July 2015

Rifaximin for Preventing Episodes of Overt Hepatic Encephalopathy (TA337)

25 March 2015

Lubiprostone for Treating Chronic Idiopathic Constipation (TA318)

23 July 2014

Prucalopride for the Treatment of Chronic Constipation in Women (TA211)

15 February 2011

Crohn's Disease: Infliximab (NICE)

9 May 2010

Ulcerative Colitis (Acute Exacerbations): Infliximab (NICE)

13 January 2009

Drug Sections (10)

GI tract in the News

High loperamide doses linked to serious cardiac reactions

By Chloe Harman, 28 September 2017

Cardiac events including QT prolongation, torsades...

NICE approves first treatment for IBS with diarrhoea

By Chloe Harman, 30 August 2017

Eluxadoline (Truberzi) can now be prescribed routinely...

Eluxadoline: first treatment option for IBS patients with diarrhoea

By Sandhiya Sodha, 19 June 2017

Truberzi (eluxadoline) is a new orally administered...

MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more

Mims

Browse news and resources by disease area